Masayuki Takanuma

Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants

Takuma Yonemura, R. Yazawa, M. Haranaka, 2022, BMC Pharmacology and Toxicology.

Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma.

K. Ohta, T. Kamei, M. Adachi, 2017, Allergology international : official journal of the Japanese Society of Allergology.